Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Express Scripts
McKesson
Medtronic
Boehringer Ingelheim

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Filibuvir

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Filibuvir: Sponsors, patents, clinical trial progress

Filibuvir is an investigational drug.

There have been 4 clinical trials for Filibuvir. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.

The most common disease conditions in clinical trials are Hepatitis C, Hepatitis, Chronic, and Hepatitis C, Chronic. The leading clinical trial sponsors are Pfizer and [disabled in preview].

There are seventeen US patents protecting this investigational drug and two hundred and forty-two international patents.

Recent Clinical Trials for Filibuvir
TitleSponsorPhase
Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone MaintenancePfizerPhase 1
Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol)PfizerPhase 1
A Study To Investigate Safety And Pharmacokinetics Of A Single Dose Of PF-00868554 (Filibuvir) In Japanese Healthy Adult VolunteersPfizerPhase 1

See all Filibuvir clinical trials

Clinical Trial Summary for Filibuvir

Top disease conditions for Filibuvir
Top clinical trial sponsors for Filibuvir

See all Filibuvir clinical trials

US Patents for Filibuvir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Filibuvir   See Pricing Method for treating HCV AbbVie Inc. (North Chicago, IL)   See Pricing
Filibuvir   See Pricing Methods for the preparation of HCV polymerase inhibitors Pfizer Inc. (New York, NY)   See Pricing
Filibuvir   See Pricing Methods for treating HCV AbbVie Inc. (North Chicago, IL)   See Pricing
Filibuvir   See Pricing Methods for treating HCV AbbVie Inc. (North Chicago, IL)   See Pricing
Filibuvir   See Pricing   See Pricing
Filibuvir   See Pricing Methods for treating HCV AbbVic Inc. (North Chicago, IL)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Filibuvir

Drugname Country Document Number Estimated Expiration Related US Patent
Filibuvir Australia 2014239563 2033-03-14   See Pricing
Filibuvir Australia 2015240754 2033-03-14   See Pricing
Filibuvir Australia 2016202823 2033-03-14   See Pricing
Filibuvir Australia 2016291154 2033-03-14   See Pricing
Filibuvir Australia 2017248487 2033-03-14   See Pricing
Filibuvir Australia 2018201011 2033-03-14   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Johnson and Johnson
AstraZeneca
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.